Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vitamin measurement
|
4 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||
HCV coinfection
|
5 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Chronic viral hepatitis
|
8 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Posterior subcapsular cataract
|
9 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Chronic liver disease
|
14 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||
Insulin resistance syndrome
|
15 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Liver Cirrhosis, Alcoholic
|
15 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Nonalcoholic Steatohepatitis
|
17 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||
Alcoholic Liver Diseases
|
20 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||
Fatty Liver
|
35 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.100 | 1.000 | 11 | 2015 | 2018 | ||||
Human immunodeficiency virus (HIV) II infection category B1
|
56 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Primary sclerosing cholangitis
|
58 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Pseudohyperkalemia Cardiff
|
60 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||
Fibrosis, Liver
|
64 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.030 | 1.000 | 3 | 2014 | 2016 | ||||
Adult Liver Carcinoma
|
72 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Liver and Intrahepatic Biliary Tract Carcinoma
|
73 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Steatohepatitis
|
75 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.100 | 1.000 | 19 | 2015 | 2020 | ||||
Hepatitis C, Chronic
|
80 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.040 | 0.750 | 4 | 2015 | 2017 | ||||
Fatty Liver Disease
|
81 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.050 | 1.000 | 5 | 2015 | 2017 | ||||
Hepatitis B, Chronic
|
84 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Malignant neoplasm of liver
|
88 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Liver diseases
|
100 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.060 | 1.000 | 6 | 2015 | 2020 | ||||
Cirrhosis
|
110 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.030 | 1.000 | 3 | 2015 | 2018 | ||||
Adrenoleukodystrophy
|
116 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Hypertriglyceridemia
|
169 | 0.630 | 0.440 | 19 | 19268740 | missense variant | C/T | snv | 6.5E-02 | 5.8E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 |